News

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form.
Investigators say the misbranded semaglutide, used in weigh loss drugs such as Wegovy, was purchased from suppliers in California and Georgia to administer to patients at a weight loss clinic.